Login / Signup

Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience.

Gianluca AvalloneFrancesco CavalloC AstruaGiacomo CaldarolaConforti ClaudioC De SimoneN di MeoA di StefaniGiovanni GenoveseCarlo Alberto MaroneseAngelo Valerio MarzanoR ParentePietro QuaglinoG RoccuzzoF TassoneI ZalaudekR SenettaSimone Ribero
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • clinical trial
  • study protocol
  • cross sectional
  • double blind
  • adverse drug
  • coronavirus disease
  • drug induced